Challenges associated with the targeted delivery of gelonin to claudin-expressing cancer cells with the use of activatable cell penetrating peptides to enhance potency.
about
Recombinant TAT-gelonin fusion toxin: synthesis and characterization of heparin/protamine-regulated cell transduction.Integrin αV modulates the cellular pharmacology of copper and cisplatin by regulating expression of the influx transporter CTR1.PTD-Modified ATTEMPTS for Enhanced Toxin-based Cancer Therapy: An In Vivo Proof-of-Concept Study.Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.Sortase-catalyzed in vitro functionalization of a HER2-specific recombinant Fab for tumor targeting of the plant cytotoxin gelonin.Characterization of a monoclonal antibody capable of reliably quantifying expression of human Copper Transporter 1 (hCTR1)Fusion protein linkers: property, design and functionality.Bioresponsive probes for molecular imaging: concepts and in vivo applications.Synergistic antitumor activity from two-stage delivery of targeted toxins and endosome-disrupting nanoparticlesTargeted tumor therapy by epidermal growth factor appended toxin and purified saponin: an evaluation of toxicity and therapeutic potential in syngeneic tumor bearing mice.Development and validation of an enzyme-linked immunosorbent assay for the quantification of gelonin in mouse plasma.In silico design of a novel chimeric shigella IpaB fused to C terminal of clostridium perfringens enterotoxin as a vaccine candidate.A Long Journey to the Cytosol
P2860
Q34345494-31E3FFD6-AB87-4774-9CBB-6D7B01B4C28AQ34781192-D43D5E15-7CB0-424F-B103-74670B353552Q35812205-3E3B7814-D56A-4FE9-8FCA-8D0B91B4D4D7Q35837949-0E348D0E-5862-4F83-8F42-27ECF2518145Q37698916-A5215574-7D2B-472C-BCD6-DC72E094C1CAQ37707059-63DA6902-1098-4D5A-80C3-E37018AB5683Q38048516-7E44BFB4-9E67-4D7B-9179-EB5FD0AAE096Q38420827-48465F36-2F10-4FC2-8A9D-DAB4713542D1Q39187821-4134D8E4-340E-40DD-8193-E92B5EB39BCBQ39214329-0359BA9B-5644-4EA3-AADD-94D928FDE99EQ39803785-94539C1E-71EB-4116-B999-9613873562FAQ47578477-EA3F3406-51DA-4581-902B-5D5CD8DBA317Q58236941-1AF7ECF2-7809-4C4D-8527-05961DADC189
P2860
Challenges associated with the targeted delivery of gelonin to claudin-expressing cancer cells with the use of activatable cell penetrating peptides to enhance potency.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Challenges associated with the ...... g peptides to enhance potency.
@ast
Challenges associated with the ...... g peptides to enhance potency.
@en
type
label
Challenges associated with the ...... g peptides to enhance potency.
@ast
Challenges associated with the ...... g peptides to enhance potency.
@en
prefLabel
Challenges associated with the ...... g peptides to enhance potency.
@ast
Challenges associated with the ...... g peptides to enhance potency.
@en
P2093
P2860
P356
P1433
P1476
Challenges associated with the ...... g peptides to enhance potency.
@en
P2093
Gerald Manorek
Stephen B Howell
Xiaoqin Yuan
Xinjian Lin
P2860
P2888
P356
10.1186/1471-2407-11-61
P407
P577
2011-02-08T00:00:00Z
P5875
P6179
1015075804